GxP Consulting has announced an expanded range of services as part of the company's growth strategy.
The company has increased its capabilities and service offerings in a number of consulting and training areas in order to support the entire drug development cycle.
This is largely part of its focused strategy to expand services and support to customers in Europe and the US, having recently opened a North American office in Irvine, California.
GxP now offers clinical project management and technology consulting, headed by Dr Neil Rotherham, biopharmaceutical process development headed by Dr Stephen Collins and strategic planning consulting, headed by Jim Stracey.
It is also offering extended capabilities in: computer systems validation, headed by Mark Wright, regulatory and validation project management, headed by Dr Tom Dine and Qualified Person (QP) services, headed by Dr Anthony Gasson.
QP services offered now include auditing/advisory services, licence application preparation through to the provision of a registered Qualified Person within a business for the purpose of product release.
GxP's QP consultants are all registered as Qualified Person under Directive 75/319 EEC.
